Fortis Healthcare’s board forms expert panel to assess binding bids
NEW DELHI | MUMBAI: Fortis Healthcare’s board is setting up an expert advisory committee under the leadership of Deepak Kapoor, former India CEO of PwC, to assess the binding bids…
P&G to acquire 52% in Merck India for Rs 1,300cr
MUMBAI: Global consumer products major, The Procter & Gamble Company (P&G), will acquire a nearly 52% stake in drug firm Merck India for Rs 1,300 crore as part of a…
Fixing medical entrance tests for a price? FIR filed
NEW DELHI: A gang of criminals targeting students appearing for MS/MD/PG diploma courses through NEET-PG examinations is on the radar of Delhi Police after several candidates complained that they were…
KKR-backed hospital chain Radiant Lifecare submits its bid for Fortis Healthcare
Radiant Lifecare, the emerging Mumbai-based hospital chain that is backed by buyout firm KKR, has submitted its bid for Fortis Healthcare, the cash-strapped hospital network that is in the middle…
NITI Aayog backs cap on pharma trade margins
New Delhi: Trade margins charged by drug stockists and chemists must be capped, government think tank NITI Aayog recommended, a move that promises to bring down drug prices while trimming…
AIOCD urges health ministry not to penalise chemists for failing to report TB cases
The All India Organisation of Chemists and Druggists Association (AIOCD), a representative body of 8.5 lakh chemists in the country, has urged the Union health ministry not to penalise chemists…
Use of Blockchain Can help Government To Bust Fake Drugs In India
According to two government sources, Niti Aayog is attempting to put the whole stock of pharma on blockchain with a purpose to take action against fake and false medications. The…
Big worry for healthcare sector: Politicization is ruining blood donation movement in Bengal
Making service and business both tougher for healthcare institutes in the state, voluntary blood donation is taking a downturn in West Bengal, that once pioneered in the life saving movement.…
Deep investigation opens unseen overpricing issues of Pharmaceutical firm
FDA may send overpricing notice to the Pharmaceutical firm. While investigating Saurya Pratap case against Medanta for overpricing, officers found the medicines used in the bill had MRP higher than…







